CVS Health Corporation - June 2023 (LTM): Peer Snapshot - Moody's Global Credit Research

CVS Health Corporation - June 2023 (LTM): Peer Snapshot

CVS Health Corporation - June 2023 (LTM): Peer Snapshot - Moody's Global Credit Research
CVS Health Corporation - June 2023 (LTM): Peer Snapshot
Published Sep 04, 2023
2 pages (536 words) — Published Sep 04, 2023
Price US$ 750.00  |  Buy this Report Now

About This Report

  
Brief Excerpt:

...Baa2 Stable Baa1 Positive Baa3 Negative Baa3 Stable CVS Health Corporation McKesson Corporation Walgreens Boots Alliance, Inc. HCA Inc.*...

  
Report Type:

Peer Snapshot

Company:
Issuer
CVS Health Corporation
Format:
PDF Adobe Acrobat
Buy Now

CVS Health Corporation: Key facts and statistics - 2023 - Issuer Profile – 2024/03/28 – US$ 200.00 – ...CVS Health Corporation (CVS Health) is a US-based health solutions company that provides integrated healthcare services. It offers health care and wellness, health insurance, pharmacy and prescription drug coverage services. As of 31 December 2023, the company served more than 35 million people through traditional, voluntary and consumer-directed health insurance products and related services, including Medicare Advantage offerings and standalone Medicare Part D prescription drug plan. The company primarily operates in the US. As of 31 December 2023, CVS Health reported more than 9,000 retail locations, over 1,000 walk-in medical clinics and 204 primary care medical clinics. In 2023, CVS Health reported total revenue of $357.8 billion. The company originated in 1963 as Consumer Value Stores in Lowell, Massachusetts, selling health and beauty products. It was renamed CVS in 1964. The company's shares are listed on the New York Stock Exchange (ticker: CVS). As of 29 December 2023, the company's...

CVS Health Corporation - December 2023 (LTM): Peer Snapshot  - Peer Snapshot – 2024/03/19 – US$ 750.00 – ...Baa2 Stable Baa1 Positive Ba2 Stable Baa3 Stable CVS Health Corporation McKesson Corporation Walgreens Boots Alliance, Inc. HCA Inc.*...

CVS Health Corporation: Update to credit analysis following ratings affirmation - Credit Opinion – 2023/12/20 – US$ 250.00 – ...CVS' credit profile reflects its large scale, leading positions in PBM and retail operations, and the strength of its Aetna brand in health insurance. CVS benefits from broad reach and solid industry fundamentals including growth in Medicare Advantage. Both the retail pharmacy and PBM businesses will benefit from rising use of prescription drugs. Transition toward a new pharmacy reimbursement model will increase transparency and help ease earnings pressure in the retail operation. Strong cash flow supports reinvestment in the business and shareholder payouts without a material increase in leverage. Tempering these strengths, CVS faces execution risk as it rapidly expands in primary care. This strategy includes the recent acquisitions of physician-led centers (Oak Street Health, Inc., i.e. "Oak Street") and integrated virtual and home healthcare assets (Signify Health, Inc., i.e. "Signify"). We anticipate lease-adjusted gross debt/EBITDA of 3.5x-4.0x over the next 12 to 18 months, including...

Moody's affirms CVS Health's Baa2 ratings; stable outlook - Rating Action – 2023/12/19 – US$ 180.00 – ...MOODY'S CREDIT RATINGS, ASSESSMENTS, OTHER OPINIONS, AND PUBLICATIONS ARE NOT INTENDED FOR USE BY RETAIL INVESTORS AND IT WOULD BE RECKLESS AND INAPPROPRIATE FOR RETAIL INVESTORS TO USE MOODY'S CREDIT RATINGS, ASSESSMENTS, OTHER OPINIONS OR PUBLICATIONS WHEN MAKING AN INVESTMENT DECISION. IF IN DOUBT YOU SHOULD CONTACT YOUR FINANCIAL OR OTHER PROFESSIONAL ADVISER. ALL INFORMATION CONTAINED HEREIN IS PROTECTED BY LAW, INCLUDING BUT NOT LIMITED TO, COPYRIGHT LAW, AND NONE OF SUCH INFORMATION MAY BE COPIED OR OTHERWISE REPRODUCED, REPACKAGED, FURTHER TRANSMITTED, TRANSFERRED, DISSEMINATED, REDISTRIBUTED OR RESOLD, OR STORED FOR SUBSEQUENT USE FOR ANY SUCH PURPOSE, IN WHOLE OR IN PART, IN ANY FORM OR MANNER OR BY ANY MEANS WHATSOEVER, BY ANY PERSON WITHOUT MOODY'S PRIOR WRITTEN CONSENT. MOODY'S CREDIT RATINGS, ASSESSMENTS, OTHER OPINIONS AND PUBLICATIONS ARE NOT INTENDED FOR USE BY ANY PERSON AS A BENCHMARK AS THAT TERM IS DEFINED FOR REGULATORY PURPOSES AND MUST NOT BE USED IN ANY WAY THAT...

CVS Health Corporation - September 2023 (LTM): Peer Snapshot - Peer Snapshot – 2023/12/04 – US$ 750.00 – Peer Snapshot: CVS Health Corporation - September 2023 (LTM) 4 December 2023 (in US millions) FYE Dec-21 FYE Dec-22 LTM Sep-23 FYE Mar-22 FYE Mar-23 LTM Sep-23 FYE Aug-21 FYE Aug-22 LTM Aug-23 FYE Dec-21 FYE Dec-22 LTM Sep-23 Revenue...

CVS Health Corporation: Strategic expansion into primary care is underway - Credit Opinion – 2023/06/21 – US$ 250.00 – ...CVS' credit profile reflects its large scale, leading positions in PBM and retail operations, and the strength of its Aetna brand in health insurance. CVS benefits from broad reach and solid industry fundamentals including growth in Medicare Advantage. Both the retail pharmacy and PBM industries will benefit from demographic trends that support rising use of prescription drugs. Strong cash flow supports deleveraging after acquisitions. Tempering these strengths, CVS faces execution risk as it rapidly expands its primary care business. This strategy includes the recent acquisitions of physician-led centers (Oak Street Health) and integrated virtual and home healthcare assets (Signify Health). Absent other large acquisitions, we anticipate lease-adjusted gross debt/EBITDA of 3.5x ¡ 3.75x over the next 12 to 18 months, including an adjustment for opioid liabilities. CVS faces intense competition, reimbursement rate pressure, and regulatory uncertainty, especially pertaining to drug pricing...

CVS Health Corporation - March 2023 (LTM): Peer Snapshot - Peer Snapshot – 2023/06/01 – US$ 750.00 – ...Baa2 Stable Baa1 Positive Baa3 Negative Baa3 Stable CVS Health Corporation McKesson Corporation Walgreens Boots Alliance, Inc. HCA Inc.*...

Moody's assigns Baa2 rating to CVS's sr. unsecured notes; stable outlook - Rating Action – 2023/05/30 – US$ 180.00 – ...MOODY'S CREDIT RATINGS, ASSESSMENTS, OTHER OPINIONS, AND PUBLICATIONS ARE NOT INTENDED FOR USE BY RETAIL INVESTORS AND IT WOULD BE RECKLESS AND INAPPROPRIATE FOR RETAIL INVESTORS TO USE MOODY'S CREDIT RATINGS, ASSESSMENTS, OTHER OPINIONS OR PUBLICATIONS WHEN MAKING AN INVESTMENT DECISION. IF IN DOUBT YOU SHOULD CONTACT YOUR FINANCIAL OR OTHER PROFESSIONAL ADVISER. ALL INFORMATION CONTAINED HEREIN IS PROTECTED BY LAW, INCLUDING BUT NOT LIMITED TO, COPYRIGHT LAW, AND NONE OF SUCH INFORMATION MAY BE COPIED OR OTHERWISE REPRODUCED, REPACKAGED, FURTHER TRANSMITTED, TRANSFERRED, DISSEMINATED, REDISTRIBUTED OR RESOLD, OR STORED FOR SUBSEQUENT USE FOR ANY SUCH PURPOSE, IN WHOLE OR IN PART, IN ANY FORM OR MANNER OR BY ANY MEANS WHATSOEVER, BY ANY PERSON WITHOUT MOODY'S PRIOR WRITTEN CONSENT. MOODY'S CREDIT RATINGS, ASSESSMENTS, OTHER OPINIONS AND PUBLICATIONS ARE NOT INTENDED FOR USE BY ANY PERSON AS A BENCHMARK AS THAT TERM IS DEFINED FOR REGULATORY PURPOSES AND MUST NOT BE USED IN ANY WAY THAT...

CVS Health Corporation - December 2022 (LTM): Peer Snapshot - Peer Snapshot – 2023/03/01 – US$ 750.00 – ...CVS Health Corporation Walgreens Boots Alliance, Inc. Rite Aid Corporation Baa2 Stable Baa3 Negative Caa2 Stable...

CVS Health Corporation: Acquisition of Oak Street will deepen reach into primary care, but at a rich price - Issuer Comment – 2023/02/09 – US$ 200.00 – ...In the latest move to become an integrated medical services provider, CVS Health Corporation (Baa2 stable) said on February 8 that it is buying Oak Street Health Inc. for $10.6 billion in cash. Oak Street is a value based primary care provider that administers care to older patients enrolled in Medicare and most Medicare Advantage health insurance plans. Value based care is a healthcare delivery model under which providers are paid based on patient health outcomes rather than for each service rendered. The $10.6 billion price tag represents a rich multiple, notwithstanding the deal's potential synergies, because Oak Street currently generates operating losses. The transaction comes at the heels of CVS' $8.2 billion acquisition of Signify (over 50x EBITDA multiple), announced in September 2022. The combination of Oak Street and Signify will expand CVS' footprint into primary and home health care. The potential for both companies to reduce the cost of care paid per patient, will also benefit...

More from Moody's Global Credit Research

Moody's Global Credit Research—Moody's Investors Service, a leading global credit rating, research and risk analysis firm, publishes credit opinions, research, and ratings on fixed-income securities, issuers of securities and other credit obligations. Credit ratings and research help investors analyze the credit risks associated with fixed-income securities. Ratings also create efficiencies in fixed-income markets and similar obligations, such as insurance and derivatives, by providing reliable, credible, and independent assessments of credit risk. For issuers, Moody's services increase market liquidity and may reduce transaction costs.

About the Author


Cite this Report

  
MLA:
Moody's Global Credit Research. "CVS Health Corporation - June 2023 (LTM): Peer Snapshot" Sep 04, 2023. Alacra Store. May 09, 2024. <http://www.alacrastore.com/moodys-credit-research/CVS-Health-Corporation-June-2023-LTM-Peer-Snapshot-PBC_1380404>
  
APA:
Moody's Global Credit Research. (). CVS Health Corporation - June 2023 (LTM): Peer Snapshot Sep 04, 2023. New York, NY: Alacra Store. Retrieved May 09, 2024 from <http://www.alacrastore.com/moodys-credit-research/CVS-Health-Corporation-June-2023-LTM-Peer-Snapshot-PBC_1380404>
  
US$ 750.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.